Diabetes Medication recalls
The FDA has published 252 recalls involving diabetes medication since 2012. The latest was reported on 21 Oct 2026. Most were for sterility. Novo Nordisk has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls 252 since 2012
Last 12 months 40 reported
Class I 16 6% of total
Ongoing 111 latest 21 Oct 2026
Recalls per month, last 24 months click a bar for that month Severity split
16 6%225 89%11 4%
Why diabetes medication is recalled
Ongoing diabetes medication recalls 111 active
All diabetes medication recalls, newest first 252 total Reported Class Recall Company Reason Where 21 Oct 2026 Drug CLASS II Tirzepatide/Niacinamide vial (40 MG per Vial) Inj 20mg/2mg/mL recalled Houston Rx Sterility Nationwide 14 Oct 2026 Drug CLASS II Semaglutide 3 MG/ML Injectable, . syringes recalled by Carolina Infusion Carolina Infusion Sterility Nationwide 14 Oct 2026 Drug CLASS II Semaglutide/cyanocobalamin 3/2 MG/ML Injectable recalled Carolina Infusion Sterility Nationwide 14 Oct 2026 Drug CLASS II Semaglutide/cyanocobalamin 9/2 MG/ML Injectable recalled Carolina Infusion Sterility Nationwide 14 Oct 2026 Drug CLASS II Tirzepatide 26 MG/ML Injectable recalled by Carolina Infusion Carolina Infusion Sterility Nationwide 14 Oct 2026 Drug CLASS II Tirzepatide/cyanocobalamin 76/2 MG/ML Injectable recalled Carolina Infusion Sterility Nationwide 14 Oct 2026 Drug CLASS II Tirzepatide/cyanocobalamin 64/2 MG/ML Injectable recalled Carolina Infusion Sterility Nationwide 14 Oct 2026 Drug CLASS II Tirzepatide/cyanocobalamin 85/2 MG/ML Injectable recalled Carolina Infusion Sterility Nationwide 14 Oct 2026 Drug CLASS II Tirzepatide Injection, 18mg/mL Sterile Multi-Dose Vial recalled Apothecary Pharma Sterility Nationwide 14 Oct 2026 Drug CLASS II Tirzepatide/cyanocobalamin 26/2 MG/ML Injectable recalled Carolina Infusion Sterility Nationwide 9 Sep 2026 Drug CLASS II Myxredlin, Insulin Human in 0.9% Sodium Chloride Injection/mL) recalled Myxredlin Baxter Healthcare Manufacturing (CGMP) Deviations Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 5mg (1mg/mL), Glycine 25 mg recalled by Apollo Care Apollo Care Particulate Matter Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 4.5mg (0.9 mg/mL) Sterile Multi-Dose Vial recalled Apollo Care Particulate Matter Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 9mg (4.5 mg/mL) Sterile Multi-Dose Vial recalled Apollo Care Particulate Matter Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 10mg (5mg/mL), Glycine 10 mg recalled by Apollo Care Apollo Care Particulate Matter Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 20mg (5mg/mL), Glycine 20 mg recalled by Apollo Care Apollo Care Particulate Matter Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 0.9mg (0.9 mg/mL) Sterile Multi-Dose Vial recalled Apollo Care Particulate Matter Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 6.75mg (4.5 mg/mL) Sterile Multi-Dose Vial recalled Apollo Care Particulate Matter Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 2.5mg (1mg/mL), Glycine 12.5 mg recalled by Apollo Care Apollo Care Particulate Matter Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 2.25MG (0.9 mg/mL) Sterile Multi-Dose Vial recalled Apollo Care Particulate Matter Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 12.5MG (2.5MG/mL) Sterile Multi-Dose Vial recalled Apollo Care Particulate Matter Nationwide 19 Aug 2026 Drug CLASS II Semaglutide 7.5mg (5mg/mL), Glycine 7.5 mg recalled by Apollo Care Apollo Care Particulate Matter Nationwide 8 Jul 2026 Drug CLASS II Synjardy XR Tablets (empagliflozin recalled by Boehringer Ingelheim Boehringer Ingelheim Pharmaceuticals Manufacturing (CGMP) Deviations OH 27 May 2026 Drug CLASS II Liraglutide Injection, 18 mg/ (6 mg/mL) recalled Liraglutide Lupin Pharmaceuticals Particulate Matter Nationwide 22 Apr 2026 Drug CLASS II Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg recalled Payless Compounders Sterility OR 11 Mar 2026 Drug CLASS II Semaglutide, For Rx compounding use only recalled Harbin Jixianglong Biotech Manufacturing (CGMP) Deviations Nationwide 11 Mar 2026 Drug CLASS II Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial recalled New Life Pharma Sterility OH 11 Mar 2026 Drug CLASS II Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial recalled New Life Pharma Sterility OH 11 Mar 2026 Drug CLASS II Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial recalled New Life Pharma Sterility OH 11 Mar 2026 Drug CLASS II Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial recalled New Life Pharma Sterility OH
Load more (222 more)
Should you stop taking Diabetes Medication?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.